CN Stock MarketDetailed Quotes

Guangdong Taienkang Pharmaceutical (301263)

Watchlist
  • 26.90
  • -0.11-0.41%
Market Closed May 15 15:00 CST
11.45BMarket Cap448.33P/E (TTM)

Guangdong Taienkang Pharmaceutical (301263) Revenue Breakdown Overview

By Product

Currency:CNY
2025/FY
Stock NameRevenueRatio
眼科用药183.36M27.17%
Gastrointestinal medication171.96M25.48%
两性健康用药153.89M22.80%
中成药及外用药90.3M13.38%
medical apparatus25.5M3.78%
Raw material medicine24.03M3.56%
医药技术服务及技术转让17.85M2.64%
其他主营产品或服务7.12M1.06%
Other business878.78K0.13%
View all

By Industry

Currency:CNY
2025/FY
Stock NameRevenueRatio
Pharmaceutical agent409.41M60.66%
Pharmaceutical manufacturing246.76M36.56%
医药技术服务及技术转让17.85M2.64%
Other business878.78K0.13%

By Country/Region

Currency:CNY
2025/FY
Stock NameRevenueRatio
South China291.43M43.18%
East China162.89M24.14%
Central China89.58M13.27%
North China43.46M6.44%
Northwest34.46M5.11%
Southwest31.21M4.62%
Northeast China20.09M2.98%
Abroad1.78M0.26%
View all

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More